Vera Therapeutics (VERA) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Corporate company logo of Vera Therapeutics Inc (VERA)

Vera Therapeutics, Inc. (VERA) is developing scientific partnerships with global centers to combat immune pathologies, complementing these efforts with the implementation of automated laboratories for precise protein analysis. The EV/EBITDA metric, accounting for debt and amortization, visualizes the outcome of these processes, with the latest value recorded as 0.00. This confirms the potential of Atacicept, which is designed to replace toxic kidney treatments and eliminate the need for dialysis for patients.

VERA Vera Corp: Enterprise Value to EBITDA Ratio in the range 11/23/2025 - 11/16/2026

Vera Therapeutics - analytical breakdowns and key metrics (VERA)

- current price and projected stock value:
Initial company analysis:Vera Therapeutics, Inc. (VERA)
Original product of veratx.com

This indicator reflects the ratio of total enterprise value, including debt, to earnings before interest, taxes, depreciation, and amortization, allowing for an assessment of the asset's value relative to its ability to generate cash flow. The current value of 0.00 and the historical EV/EBITDA level of Vera Therapeutics, Inc. (VERA) depend critically on the financial runway and the success of atacicept clinical trials, determining the long-term capitalization potential.

Who Vera Therapeutics, Inc. competes with

EV/EBITDA Multiple ARGX (argenx.com)|Total Company Value to Operating Income Before Depreciation Ratio biontech.de (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ADMA Biologics Inc (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist Corp (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant, Inc.|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple grifols.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies Corp (ADPT)|Celldex Therapeutics, Inc. - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (auriniapharma.com)|BioCryst Pharmaceuticals Inc (BCRX) - Company Value to EBITDA|Dianthus Therapeutics, Inc. - EV/EBITDA Multiple|Company Value to Operating Income Before Depreciation Ratio PHVS|ABCL: EV/EBITDA Multiple|Company Value to EBITDA Tourmaline Corp (TRML)|PGEN (precigen.com) - EV/EBITDA Multiple|EV/EBITDA Multiple Pharming Corp|Enterprise Value to EBITDA Ratio NKTR (Nektar)|UPB (Upstream Bio Inc) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zenas Bio ZBIO|IMNM: Enterprise Value to Operating Income Before Depreciation|GOSS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio KalVista Pharmaceuticals KALV|Septerna (SEPN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|pieris.com - Business Value to Operating Income Before Depreciation|SVRA (Savara Inc) - EV/EBITDA Multiple|RIGL: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ANAB|ATXS (Astria Pharma) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization enGene Holdings Inc. ENGN|EV/EBITDA Multiple RAPT Therapeutics Inc. RAPT|Aerovate Therapeutics - EV/EBITDA Multiple|Company Value to EBITDA Aclaris Therapeutics Inc.|Kyverna (KYTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Tiziana Life Sciences (TLSA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cabaletta Bio Inc.|Ventyx Biosciences (VTYX) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple THTX|EV/EBITDA Multiple Avalo Therapeutics Inc. (AVTX)|EV/EBITDA Multiple ELDN (eledon.com)|AGEN - Enterprise Value to EBITDA Ratio|CLYM: Enterprise Value to EBITDA Ratio|ZURA (Zura Bio Limited) - Enterprise Value to Operating Income Before Depreciation|ATYR: EV/EBITDA Multiple|Adagene (ADAG) - EV/EBITDA Multiple|IMA (ikenaoncology.com) - EV/EBITDA Multiple|shattucklabs.com (STTK) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Equillium Inc (EQ)|Connect Pharma - Enterprise Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Immunic, Inc. IMUX|ATRA - Enterprise Value to EBITDA Ratio|IFRX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|XFOR: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ACET: EV/EBITDA Multiple|Celularity Corp (CELU) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INmune Bio|Barinthus Biotherapeutics plc (BRNS) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple KZR|SABS: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AKTX (Akari Therapeutics, Plc)|ENLV (Enlivex Therapeutics, Ltd.) - Company Value to Operating Income Before Depreciation Ratio|QTTB: Enterprise Value to EBITDA Ratio|GOVX - EV/EBITDA Multiple|Edesa Biotech Corp (EDSA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|IBIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization carismatx.com|XTLB: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Biotherapeutics Inc. (BOLT)|HCWB (HCW Biologics) - Business Value to Operating Income Before Depreciation|Aptevo Therapeutics - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple AIM ImmunoTech Inc. AIM|Aditxt Inc. - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation GRI (GRI Bio, Inc.)|XORTX Therapeutics Inc (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio ReShape Lifesciences|Enterprise Value to EBITDA Ratio REVB|Indaptus Corp (INDP) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization scinai.com (SCNI)|Enterprise Value to EBITDA Ratio CalciMedica CALI|EV/EBITDA Multiple AFMD (affimed.com)|Allakos Inc. (ALLK) - Company Value to EBITDA|HOOKIPA - EV/EBITDA Multiple|IGMS (igmbio.com) - Enterprise Value to Operating Income Before Depreciation|ITOS (iTeos) - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation OCEA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC BioPharm|Third Harmonic Bio Inc. (THRD) - Total Company Value to Operating Income Before Depreciation Ratio